Khaled Musallam/LinkedIn
Sep 8, 2026, 08:23
Khaled Musallam: A Masterclass on Thalassemia Care in the MENA Region
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared a post on LinkedIn:
“Looking forward to this virtual 2-day Masterclass: ‘The MENA Thalassemia Experience’ on 30-31 October 2026.
This masterclass is developed and organized in collaboration with the Thalassaemia International Federation (TIF) and Medscape Education Global.
The immersive 2-day masterclass is designed for both experienced physicians and physicians in training across the Middle East and North Africa (MENA) region.
Limited ‘seats’ available, apply now to secure your place!”
Find more posts featuring Khaled Musallam on Hemostasis Today.
-
Oct 16, 2026, 17:06Troels Wienecke: Connecting Myeloproliferative Disease and Ischemic Stroke
-
Oct 16, 2026, 17:03Only 5 Days Left to Submit Your Research for EAHAD 2027
-
Oct 16, 2026, 16:48Abdul Rahman: Reticulocyte Count and Bone Marrow Activity
-
Oct 16, 2026, 16:44DOAC Adherence in Stroke Patients With Atrial Fibrillation – International Journal of Stroke
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification